Skip to main content
Figure 3 | Journal of Hematology & Oncology

Figure 3

From: The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients

Figure 3

The subgroup analysis for the association of serum CXCL13 with overall survival based on stage and EBV DNA positivity in blood. (A, B) High CXCL13 levels are associated with lower overall survival among patients with non-detectable EBV titers and stage I/II disease. (C, D) CXCL13 fails to predict prognosis in patients with advanced disease and detectable EBV titers.

Back to article page